Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12TAKEDA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1948

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-12

blank

02

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1701

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank

03

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1701

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank

04

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1948

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-12

blank

05

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1700

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank

06

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1948

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-12

blank

07

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1701

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank

08

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1700

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank

09

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1700

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank

10

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 11384086

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1948

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-12

blank